rs121908327
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001127198.5(TMC6):c.280C>T(p.Arg94*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,550,686 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R94R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001127198.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- epidermodysplasia verruciformis, susceptibility to, 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- epidermodysplasia verruciformisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMC6 | NM_001127198.5 | c.280C>T | p.Arg94* | stop_gained | Exon 5 of 20 | ENST00000590602.6 | NP_001120670.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMC6 | ENST00000590602.6 | c.280C>T | p.Arg94* | stop_gained | Exon 5 of 20 | 2 | NM_001127198.5 | ENSP00000465261.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000257 AC: 4AN: 155604 AF XY: 0.0000365 show subpopulations
GnomAD4 exome AF: 0.0000250 AC: 35AN: 1398486Hom.: 1 Cov.: 33 AF XY: 0.0000304 AC XY: 21AN XY: 689842 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74356 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 36705400, 18158319, 12426567) -
Epidermodysplasia verruciformis Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg94*) in the TMC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TMC6 are known to be pathogenic (PMID: 15042430, 17139267). This variant is present in population databases (rs121908327, gnomAD 0.02%), including at least one homozygous and/or hemizygous individual. This premature translational stop signal has been observed in individual(s) with epidermodysplasia verruciformis (PMID: 12426567). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4748). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Epidermodysplasia verruciformis, susceptibility to, 1 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at